TR
Tessa Romero JP Morgan Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Edgewise Therapeutics
EWTX
$1.57B
| $14.75 | $30 |
103%
upside
| Overweight |
19 Aug ‘25
22 days ago |
|
2
Acadia Pharmaceuticals
ACAD
$4.28B
| $24.84 | $34 |
37%
upside
| Overweight |
24 Jul ‘25
1 month ago |
|
3
Dyne Therapeutics
DYN
$1.88B
| $13.25 | $9 |
32%
downside
| Neutral |
15 Jul ‘25
1 month ago |
|
4
Biohaven
BHVN
$1.53B
| $14.48 | $55 |
280%
upside
| Overweight |
18 Jun ‘25
2 months ago |
|
5
Cytokinetics
CYTK
$6.16B
| $51.50 | $53 |
3%
upside
| Overweight |
9 Jun ‘25
3 months ago |
|
6
Lexeo Therapeutics
LXEO
$284M
| $5.19 | $10 |
93%
upside
| Overweight |
30 May ‘25
3 months ago |
|
|
UPB
7
Upstream Bio, Inc. Common Stock
UPB
$1.01B
| $18.24 | $38 |
108%
upside
| Overweight |
5 Nov ‘24
10 months ago |
|
8
Neumora Therapeutics
NMRA
$269M
| $1.67 | $15 |
798%
upside
| Neutral |
5 Nov ‘24
10 months ago |
|
9
Scholar Rock
SRRK
$3.04B
| $31.58 | $31 |
2%
downside
| Overweight |
14 Oct ‘24
11 months ago |
|
10
EyePoint Pharmaceuticals
EYPT
$941M
| $14.19 | $29 |
104%
upside
| Overweight |
13 Aug ‘24
1 year ago |
|
11
Agios Pharmaceuticals
AGIO
$2.1B
| $36.15 | $46 |
27%
upside
| Neutral |
13 Jun ‘24
1 year ago |
|
12
Y-mAbs Therapeutics
YMAB
$390M
| $8.58 | $7 |
18%
downside
| Underweight |
22 Aug ‘23
2 years ago |
|
13
Xenon Pharmaceuticals
XENE
$2.89B
| $37.51 | $55 |
47%
upside
| Overweight |
25 Apr ‘23
2 years ago |
|